.gif "LifePoint Health logo")
LifePoint Health, Inc. (NASDAQ:LPNT) has received a consensus rating of “Hold” from the seventeen analysts that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $66.18.
Several research analysts have commented on LPNT shares. BidaskClub downgraded shares of LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price objective on shares of LifePoint Health in a research report on Wednesday, July 5th. Zacks Investment Research cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. Leerink Swann raised shares of LifePoint Health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $73.00 to $74.00 in a research note on Tuesday, June 6th. Finally, Morgan Stanley initiated coverage on shares of LifePoint Health in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price objective on the stock.
ILLEGAL ACTIVITY WARNING: “LifePoint Health, Inc. (LPNT) Receives Consensus Recommendation of “Hold” from Brokerages” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://stocknewstimes.com/2017/08/17/lifepoint-health-inc-lpnt-receives-consensus-rating-of-hold-from-brokerages-updated-updated.html.
Shares of LifePoint Health (LPNT) traded down 0.17% during midday trading on Monday, hitting $58.65. The company had a trading volume of 475,902 shares. LifePoint Health has a one year low of $50.60 and a one year high of $70.95. The firm has a market cap of $2.35 billion, a price-to-earnings ratio of 13.13 and a beta of 0.86. The company’s 50 day moving average is $64.19 and its 200 day moving average is $62.87.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.69 earnings per share. The firm’s quarterly revenue was up .2% on a year-over-year basis. Equities analysts forecast that LifePoint Health will post $4.07 earnings per share for the current fiscal year.
In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total value of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares in the company, valued at approximately $32,365,920.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard H. Evans sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total transaction of $125,760.00. Following the completion of the sale, the director now owns 17,718 shares in the company, valued at $1,114,107.84. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 102,000 shares of company stock valued at $6,556,824. 7.28% of the stock is owned by insiders.
Several hedge funds have recently bought and sold shares of the stock. BlackRock Inc. increased its position in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after buying an additional 3,714,004 shares in the last quarter. Dimensional Fund Advisors LP increased its position in LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock valued at $221,969,000 after buying an additional 18,327 shares during the period. Vanguard Group Inc. increased its position in LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock valued at $213,986,000 after buying an additional 120,201 shares during the period. Wellington Management Group LLP increased its position in LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock valued at $213,351,000 after buying an additional 168,451 shares during the period. Finally, Alliancebernstein L.P. increased its position in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock valued at $113,049,000 after buying an additional 68,886 shares during the period. Hedge funds and other institutional investors own 99.27% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
